Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 16;80(7):722-738.
doi: 10.1016/j.jacc.2022.06.009.

Management of Patients With Severe Mitral Annular Calcification: JACC State-of-the-Art Review

Omar Chehab  1 , Ross Roberts-Thomson  2 , Antonio Bivona  1 , Harminder Gill  3 , Tiffany Patterson  4 , Amit Pursnani  5 , Karine Grigoryan  1 , Bernardo Vargas  5 , Ujala Bokhary  5 , Christopher Blauth  1 , Gianluca Lucchese  1 , Vinayak Bapat  6 , Mayra Guerrero  7 , Simon Redwood  4 , Bernard Prendergast  8 , Ronak Rajani  9
Affiliations
Free article
Review

Management of Patients With Severe Mitral Annular Calcification: JACC State-of-the-Art Review

Omar Chehab et al. J Am Coll Cardiol. .
Free article

Abstract

Mitral annular calcification (MAC) is a common and challenging pathologic condition, especially in the context of an aging society. Surgical mitral valve intervention in patients with MAC is difficult, with varying approaches to the calcified annular anatomy, and the advent of transcatheter valve interventions has provided additional treatment options. Advanced imaging provides the foundation for heart team discussions and management decisions concerning individual patients. This review focuses on the prognosis of, preoperative planning for, and management strategies for patients with MAC.

Keywords: mitral annular calcification; mitral valve; surgery; valve-in-MAC.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Lucchese has been a consultant for and received speaker fees from Edwards Lifesciences, Cryolife, and Bard-DB. Dr Bapat has received speaker/consultancy fees and research grant support from Edwards Lifesciences, Medtronic, Boston Scientific, and Abbott. Dr Guerrero has received research grant support from Abbott Structural Heart and Edwards Lifesciences. Dr Redwood has received speaker fees from Edwards Lifesciences. Dr Prendergast has received unrestricted research and educational grants from Edwards Lifesciences; and has received speaker/consultancy fees from Abbott, Medtronic, Microport, Anteris, and Edwards Lifesciences. Dr Rajani has received speaker/consultancy fees from Siemens Healthineers, GE Healthcare, Medtronic, and Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

MeSH terms